We aimed to determine LAL activity in a cohort of NAFLD subjects and in a control group of hepatitis C virus (HCV)-infected patients, investigating the role of liver cirrhosis. The gene discussed is LIPA; the disease is metabolic dysfunction-associated steatotic liver disease.